TACTIC Stakeholders

Hear2Care

Tingting Zhang PhD currently leads the TACTIC Initiative

EGFRResisters

Jill Feldman Co-Founder

Advocates for Collaborative Education

Stacey Tinianov Executive Director

Patient Centered Dosing Initiative

METAvivor

Janice Cowden

Lobular Breast Cancer Alliance

Gitte H Joergensen PhD

Inflammatory Breast Cancer Research Foundation

Ginny Mason Executive Director

Advocates for Universal DPD/DPYD Testing

Karen Merritt

Patient Advocates at SWOG

TBD

Independent Advocates

Sarah M Greene

JJ Singleton: “I’m long-term survivor of early-onset stage 4 terminal colorectal cancer. Diagnosed in September 2015 at the age of 27, I’ve spent over a decade navigating treatments 190 and counting while dedicating my life to cancer advocacy, breaking down stigma for young men, and reshaping clinical trial transparency as well as advocating for colorectal cancer and rural healthcare and oncology.”

Anna Hedden

IN MEMORIAM

Amy Buemer PhD “Amy was diagnosed with Stage I breast cancer as well as extensive ductal carcinoma in situ (DCIS) in 2017, at the age of 38, a newly married assistant professor with a PhD in microbiology… Her work spanned legislative advocacy, peer support and mentoring, research, and education… Amy was also a trained peer support group leader and patient advocate grant reviewer for METAvivor, eventually becoming a member of its Board of Directors… She was also a team member supporting the Patient Centered Dosing Initiative, working to educate healthcare professionals and patients on the benefits of partnering to determine a personalized dose of cancer drugs with the aim of easing severe side effects, and allowing patients to stay on treatments longer while maintaining effectiveness.” -MBC Alliance JUNE 12, 2026


Reagan-Udall Foundation for the FDA

Carla V Rodriguez PhD leads the UPLIFT “Understanding the Patient’s Landscape In the Face of Treatment toxicities” effort

Multinational Association of Supportive Care in Cancer (MASCC)

Maryam Lustberg MD served as President of MASCC between 2022 and 2024.

Hope Rugo MD Leads MASCC Emerging Toxicities Study Group

American Socitiesy of Clinical Oncology (ASCO)

Eric Roeland MD leads ASCO ASPirE “Alliance for Support and Prevention of Immune-Related Adverse Events”

Tony KW Hung MD

Rutikan Mehta MD

Joanna Metzner-Sadurski MD is a member of ASCO Health Policy Committee

Oncology Nursing Society

Darcy Burbage

The Health and Environmental Sciences Institute (HESI)

Syril Pettit D. PH Executive Director